ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Jennewein Biotechnologie, a German producer of rare functional sugars, has acquired former facilities of Arthus Mineralsprings to boost its fermentation production of human milk oligosaccharides, used in infant formula. Currently, Jennewein produces 2'‑fucosyllactose and lacto-N-neotetraose; the deal will add 3‑fucosyllactose, difucosyllactose, lacto-N-tetraose, 6-sialyllactose, and 3-sialyllactose. In September, the company unveiled a new route that uses simple sugars rather than lactose as feedstock.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X